Vulnerability and Risk of Neuropathic Pain in Cancer

Inclusion Criteria Patients: * Patient over 18 years of age, * Patient suffering from cancer (breast, gynecological, colorectal, lung) and having to undergo one or more anti-cancer therapeutic procedures (chemotherapy, surgery, hormonal therapy, radiotherapy, targeted therapy, etc.), * Sufficient cooperation and understanding to comply with the study requirements, * Agreement to give oral consent for the study, * Affiliation with the French Social Security system. Exclusion Criteria Patients: * History of cancer and anti-cancer therapy (surgery, chemotherapy, radiotherapy, hormone therapy, targeted therapy, etc.), * History and/or presence of primary brain tumors (glioblastoma, meningioma, neurofibroma, etc.) ), * History of neurological disorders (Parkinson's disease, Alzheimer's disease, dementia, epilepsy, moderate to severe head trauma, etc.), * Medical and/or surgical history judged by the investigator or his representative to be incompatible with the study, * Subject whose cooperation and understanding do not allow strict compliance with the conditions laid down in the protocol, * Pregnant or breast-feeding women, * Beneficiary of a legal protection measure. Inclusion Criteria Healthy Volunteers: * Subject over 18 years of age, * Subject free of any treatment in the 7 days preceding inclusion, in particular no use of analgesics, or judged by the investigator or his representative to be compatible with the study * Subject with no history of cancer, * Subject considered to be in good health by the investigator, * Sufficient cooperation and understanding to comply with the study requirements, * Agreement to give oral consent to the study, * Affiliation with the French Social Security system, Exclusion Criteria Healthy Volunteers: * Subjects with a medical and/or surgical history judged by the investigator or his representative to be incompatible with the trial, * Subjects whose cooperation and understanding do not allow strict compliance with the conditions laid down in the protocol, * Pregnant or breast-feeding woman, * Participating in another clinical trial, or within the exclusion period, or having received a total amount of compensation exceeding 4500 euros over the 12 months preceding the start of the trial, * Benefiting from a legal protection measure.